Tech Company Financing Transactions
Benevir Funding Round
Benevir, operating out of Gaithersburg, raised $3 million from private investors.
Transaction Overview
Company Name
Announced On
2/16/2016
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Investors
Proceeds Purpose
This February 2016 A-2 tranche is for $1M, which is in addition to the previous $2M tranche completed in November 2014. Proceeds purposes were not disclosed. __ investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
708 Quince Orchard Rd. 150
Gaithersburg, MD 20878
USA
Gaithersburg, MD 20878
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
The BeneVir oncolytic virus platform is based on T-StealthTM technology, which overcomes a major barrier to the clinical success of oncolytic viruses.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Mulvey
Chief Scientific Officer
Ian Mohr
Founder
Katherine Sacksteder
VP - R & D
Steven Fuhrmann
Browse more venture capital transactions:
Prev: 2/16/2016: Vive Lifestyle venture capital transaction
Next: 2/16/2016: WigWag venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs